Organon's SWOT analysis: stock poised for growth amid challenges By...

Published on 18 Dec 2024 on Investing.com

Organon (NYSE:OGN), a prominent player in the healthcare sector specializing in women's health and...

Read the rest of the article

Start tracking your investments with Statfolio

Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...

Zacks · via Yahoo Finance 20 Dec 2024

The cream, an aryl hydrocarbon receptor agonist, was previously approved as a topical, nonsteroid...

McKnight’s Senior Living 19 Dec 2024

Organon (NYSE:OGN), a prominent player in the healthcare sector specializing in women's health an...

Investing.com 18 Dec 2024

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, dru...

MedPage Today 17 Dec 2024

The HealthCare Institute of New Jersey (HINJ) and Organon hosted the “Advancing Women’s Health”...

New Jersey Business Magazine 17 Dec 2024

Organon (OGN) announced that the U.S. Food and Drug Administration or FDA has approved VTAMA or...

TipRanks · via Yahoo Finance 17 Dec 2024

First Lady Tammy Murphy held her 7th annual Nurture NJ Leadership Summit in East Brunswick this p...

New Jersey Business Magazine 11 Dec 2024

These 21 New Jersey-based firms made the 2025 list. Last year, 18 Garden State businesses landed ...

NJBIZ 10 Dec 2024

Representing 30.10% of the portfolio, the fund has heaviest allocation to the Financials sector;...

Zacks · via Yahoo Finance 10 Dec 2024

The association between untreated infertility and SARD persisted in analyses restricted to women...

Medscape 9 Dec 2024